Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 12, 2012 - Issue 11
Submit an article Journal homepage
76
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Sublobar/wedge resection or stereotactic body radiation therapy for stage I marginally operable non-small-cell lung cancer

Somu Suppiah Southern Illinois University Medical School, Springfield, IL, USA
,
Philip Linden Division of Thoracic Surgery, Department of Surgery, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH, USA
,
Jason Robke Division of Thoracic Surgery, Department of Surgery, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH, USA
,
Carsten Schroeder Division of Thoracic Surgery, Department of Surgery, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH, USA
,
Min Yao Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA
,
Mitchell Machtay Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA
&
Simon S Lo Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA. [email protected]
 show all
Pages 1375-1377 | Published online: 10 Jan 2014

References

  • Forquer JA, Fakiris AJ, McGarry RC et al. Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy. Expert Rev. Anticancer Ther. 9(10), 1443–1453 (2009).
  • Fernando HC, Schuchert M, Landreneau R, Daly BT. Approaching the high-risk patient: sublobar resection, stereotactic body radiation therapy, or radiofrequency ablation. Ann. Thorac. Surg. 89(6), S2123–S2127 (2010).
  • McGarry RC, Song G, des Rosiers P, Timmerman R. Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest 121(4), 1155–1158 (2002).
  • Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM. Natural history of stage I non-small-cell lung cancer: implications for early detection. Chest 132(1), 193–199 (2007).
  • Powell JW, Dexter E, Scalzetti EM, Bogart JA. Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials. Lancet Oncol. 10(9), 885–894 (2009).
  • Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small-cell lung cancer. Lung Cancer Study Group. Ann. Thorac. Surg. 60(3), 615–622; discussion 622 (1995).
  • Lo SS, Fakiris AJ, Chang EL et al. Stereotactic body radiation therapy: a novel treatment modality. Nat. Rev. Clin. Oncol. 7(1), 44–54 (2010); Erratum in: Nat. Rev. Clin. Oncol. 7(8), 422 (2010).
  • Timmerman R, Paulus R, Galvin J et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303(11), 1070–1076 (2010).
  • Grills IS, Mangona VS, Welsh R et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J. Clin. Oncol. 28(6), 928–935 (2010).
  • Crabtree TD, Denlinger CE, Meyers BF et al. Stereotactic body radiation therapy versus surgical resection for stage I non-small-cell lung cancer. J. Thorac. Cardiovasc. Surg. 140(2), 377–386 (2010).
  • Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman B, Senan S. Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. Radiother. Oncol. 101(2), 240–244 (2011).
  • Louie AV, Rodrigues G, Hannouf M et al. Stereotactic body radiotherapy versus surgery for medically operable stage I non-small-cell lung cancer: a Markov model-based decision analysis. Int. J. Radiat. Oncol. Biol. Phys. 81(4), 964–973 (2011).
  • Puri V, Crabtree TD, Kymes S et al. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis. J. Thorac. Cardiovasc. Surg. 143(2), 428–436 (2012).
  • Fernando HC, Timmerman R. American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: a randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small-cell lung cancer. J. Thorac. Cardiovasc. Surg. 144(3), S35–S38 (2012).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.